Insider Holders & Insider Ownership - RespireRx Pharmaceuticals Inc. (RSPI)

List of insiders holdings for RespireRx Pharmaceuticals Inc.:
  1. Shares directly owned by the insider.
  2. Shares indirectly owned by the insider.
  3. Total shares owned by the insider (sum of shares directly and indirectly owned).
  4. Total market value if available.
  5. Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Insider Holder NameReport
Date Time
Shares Owned
Directly
Indirectly
Total
Shares Owned
Filing
Margolis Jeff Eliot
SVP, CFO, Secret'y & Treasurer
10% Owner
2020-10-02 15:47:00171
107,048,385
107,048,556Form 4
AURORA CAPITAL LLC
Member of a 10% owner group
2013-06-19 16:32:1724,200,507
0
24,200,507Form 13D
ORIGIN VENTURES II LP
Origin Ventures II Management LLC
BARRON BRUCE N
Miller Steven N.
10% Owner
2013-06-19 16:35:1724,200,507
0
24,200,507Form 13G
samyang optics co. ltd
Samyang Value Partners Co. Ltd.
10% Owner
2013-06-19 16:39:2222,113,831
0
22,113,831Form 13D
IllinoisVentures GP LLC
ILLINOIS EMERGING TECHNOLOGIES FUND LP
10% Owner
2012-08-20 16:48:4120,334,546
0
20,334,546Form 13G
Jones Timothy L.
CEO and President
2020-10-02 15:51:438,818,154
0
8,818,154Form 4
MacFarlane Katie
Director
2020-10-02 15:50:565,000,000
0
5,000,000Form 4
Purcell Richard David Jr.
SVP - Research and Development
2020-08-04 14:25:585,000,000
0
5,000,000Form 4
Radin Marc M
Controller
2014-04-16 20:14:054,000,000
0
4,000,000Form 4
STOLL ROGER G PHD
Executive Chairman
2012-08-14 16:05:053,083,334
0
3,083,334Form 4
AURORA CAPITAL CORP
Member of 10% owner group
2013-04-01 18:01:290
2,971,792
2,971,792Form 3
T. Morgen Capital LLC
Member of 10% owner group
2013-04-01 17:34:520
2,971,792
2,971,792Form 3
COLEMAN JAMES H
Sr. VP, Business Development
2012-08-14 16:04:282,083,334
0
2,083,334Form 4
Dickason David
SVP of Pre-Clinical Prod. Dev.
2020-10-06 15:20:382,000,000
0
2,000,000Form 4
Carley David W.
Director
2012-08-20 16:12:321,899,158
0
1,899,158Form 4
MANUSO JAMES S J
President and CEO
2017-12-12 18:49:471,198,149
0
1,198,149Form 4
Letendre Peter
Director
2012-08-20 16:05:12684,031
0
684,031Form 4
Cohen Kenneth M
Member of 10% owner group
2013-04-01 18:20:30656,755
0
656,755Form 3
Varney Mark A
President and CEO
2009-08-24 19:28:31588,000
0
588,000Form 4
Benedik John F
Director
2012-08-07 16:11:20493,333
0
493,333Form 4
JOHNSON M ROSS
Director
2012-08-07 16:16:07428,333
0
428,333Form 4
DRAKE PETER F
Director
2012-08-07 16:15:11406,667
0
406,667Form 4
CASAMENTO CHARLES J
Director
2012-08-07 16:13:17406,667
0
406,667Form 4
MESSINGER MARIA S
Chief Financial Officer
2009-08-24 19:22:15380,000
0
380,000Form 4
ALLNUTT ROBERT
Director
2012-08-07 16:10:34363,333
0
363,333Form 4
Chizzik Steven
Member of 10% owner group
2013-04-01 18:07:36330,199
0
330,199Form 3
COTMAN CARL W
Director
2012-08-07 16:14:00276,667
0
276,667Form 4
WEINGARTEN ROBERT N
EVP & Chief Financial Officer
2017-01-20 21:10:36216,156
0
216,156Form 4
SAPIRSTEIN JAMES
Director
2017-12-12 19:38:21134,269
0
134,269Form 4
Mansbach Harry H
Chief Medical Officer
2005-12-05 12:28:13100,000
0
100,000Form 4
ROGERS GARY ALLEN
Sr VP, Pharmaceutical Research
2007-02-07 19:33:380
58,399
58,399Form 5
Tran Pierre V
Chief Medical Officer
2009-08-24 19:24:5350,000
0
50,000Form 4
TOLLEFSON GARY D
Director
2008-02-13 19:14:2330,000
0
30,000Form 4
Lippa Arnold
Exec. Chairman & CSO
2020-10-02 15:47:42100
0
100Form 4
Johnson Steven Andrew
VP, Preclinical Development
2010-02-02 20:46:540
0
0Form 5
Hwang Moogak
Director
2012-08-09 18:24:370
0
0Form 3
HYER KATHRYN BURRER
Director
2012-08-14 13:42:180
0
0Form 3